First Tracks Biotherapeutics, Inc. (TRAX)

Healthcare · Biotechnology · NASDAQ

First Tracks Biotherapeutics, Inc. (TRAX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.47B and a free-cash-flow yield of -6.6%.

Market cap	$1.47B
Trailing P/E	—
FCF yield	-6.6%
Revenue growth (YoY)	—
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live TRAX data on Nama Insights →